MedPath

Laparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can Be Removed By Surgery

Not Applicable
Withdrawn
Conditions
Recurrent Rectal Cancer
Stage II Rectal Cancer
Stage I Rectal Cancer
Stage III Rectal Cancer
Interventions
Procedure: conventional laparoscopic surgery
Procedure: robotic-assisted laparoscopic surgery
Procedure: quality-of-life assessment
Other: questionnaire administration
Registration Number
NCT01196000
Lead Sponsor
City of Hope Medical Center
Brief Summary

RATIONALE: Robotic-assisted laparoscopic surgery may be a less invasive type of surgery for rectal cancer and may have fewer side effects and improve recovery. It is not yet known whether robotic-assisted laparoscopic surgery is more effective than laparoscopic surgery in treating patients with rectal cancer.

PURPOSE: This randomized clinical trial studies robotic-assisted laparoscopic surgery to see how well it works compared to laparoscopic surgery in treating patients with rectal cancer that can be removed by surgery.

Detailed Description

OBJECTIVES:

I. To evaluate robotic-assisted rectal cancer surgery versus standard laparoscopic rectal cancer resection by means of a randomized, controlled trial.

II. To assess technical ease of the operation, as determined by the clinical indicator of low conversion rate to open operation.

III. To assess surgical accuracy and improved oncological outcome as determined by clear pathological resection margins.

IV. To assess quality of life and analyze cost-effectiveness to aid evidence-based knowledge to inform NHS and other service providers and decision-makers.

V. To analyze disease-free and overall survival and local recurrence rates at 3-year follow-up.

OUTLINE:

Patients are randomized to 1 of 2 treatment arms.

ARM I: Patients undergo standard laparoscopic resection.

ARM II: Patients undergo robotic-assisted laparoscopic resection.

After completion of study treatment, patients are followed up at 1 month, 6 months, and then annually thereafter for 3 years.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm Iquestionnaire administrationPatients undergo standard conventional laparoscopic resection.
Arm IIquality-of-life assessmentPatients undergo robotic-assisted laparoscopic resection.
Arm Iconventional laparoscopic surgeryPatients undergo standard conventional laparoscopic resection.
Arm IIrobotic-assisted laparoscopic surgeryPatients undergo robotic-assisted laparoscopic resection.
Arm IIquestionnaire administrationPatients undergo robotic-assisted laparoscopic resection.
Arm Iquality-of-life assessmentPatients undergo standard conventional laparoscopic resection.
Primary Outcome Measures
NameTimeMethod
Rate of conversion to open surgery as an indicator of surgical technical difficultyAt completion of surgery
Secondary Outcome Measures
NameTimeMethod
Circumferential resection margin positivity rateAt completion of pathology review
Intra-operative laparoscopic skills (randomly selected cases only) as assessed by the global assessment tool for evaluation of intra-operative laparoscopic skills (GOALS)Upon completion of GOALS assessment by an independent expert
Health economicsAt day 30 and 6 months
Local recurrence rateAt 3 years
Self reported bladder and sexual functionAt day 30 and 6 months
Health related quality of lifeAt day 30 and 6 months
Intra-operative and post-operative complicationsAt day 30 and 6 months
Operative mortalityAt day 30
Disease free and overall survivalAt 3 years
Quality of the plane of surgery as assessed by central review of photographsAt completion of the central review of photographs
© Copyright 2025. All Rights Reserved by MedPath